Announcements Trials

Browse Landscape

Phase

Phase 2/3 2 Phase 2 1

Status

Terminated 2 Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 198 Nivolumab 146 Carboplatin 133 Specimen Handling 130 Magnetic Resonance Spectroscopy 116 Cyclophosphamide 112 Paclitaxel 106 Biopsy 97 Cisplatin 94 Radiotherapy 89 durvalumab 83 Dexamethasone 80 atezolizumab 73 Ipilimumab 66 Gemcitabine 60 Doxorubicin 60 Rituximab 59 Lenalidomide 56 Docetaxel 55 olaparib 51 Etoposide 51 Bevacizumab 51 Fluorouracil 49 Capecitabine 49 Radiation 47 Oxaliplatin 47 Radiosurgery 43 Prednisone 43 venetoclax 41 Taxes 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Active not recruiting × AC protocol × Clear all

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡